Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid Metabolism in a Population With Metabolic Syndrome

NCT02041104 is registered in ClinicalTrials.gov with Mlinotest Zivilska Industrija d.d. as lead sponsor.

NCT NCT02041104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02041104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid Metabolism in a Population With Metabolic Syndrome
Lead sponsor
Mlinotest Zivilska Industrija d.d.
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2014
Completion date
April 30, 2018
Enrollment
51 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, hyperglycemia, hypertension, metabolic syndrome, obesity, abdominal